Amgen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Amgen and other ETFs, options, and stocks.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment.
CEORobert A. Bradway
CEORobert A. Bradway
Employees26,700
Employees26,700
HeadquartersThousand Oaks, California
HeadquartersThousand Oaks, California
Founded1980
Founded1980
Employees26,700
Employees26,700
AMGN Key Statistics
Market cap172.45B
Market cap172.45B
Price-Earnings ratio55.55
Price-Earnings ratio55.55
Dividend yield2.75%
Dividend yield2.75%
Average volume1.75M
Average volume1.75M
High today$322.50
High today$322.50
Low today$319.06
Low today$319.06
Open price$321.34
Open price$321.34
Volume1.17M
Volume1.17M
52 Week high$346.85
52 Week high$346.85
52 Week low$249.70
52 Week low$249.70
AMGN News
Benzinga 13h
Deere, Amgen, Copart And More: CNBC's 'Final Trades'On CNBC's “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners named Deere & Company DE as his final trade. On Wednesday, Citigroup analyst Kyle Me...
TipRanks 2d
RBC Capital remains bullish on Regeneron, continues to see buying opportunityRBC Capital notes that Regeneron (REGN) is down over $150 per share since the District Court judge denied the company’s motion for a preliminary injunction agai...
Simply Wall St 4d
Insiders At Amgen Sold US$4.0m In Stock, Alluding To Potential WeaknessThe fact that multiple Amgen Inc. (NASDAQ:AMGN) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst in...
Analyst ratings
50%
of 32 ratingsBuy
50%
Hold
43.8%
Sell
6.3%
More AMGN News
TipRanks 4d
Amgen price target raised to $315 from $300 at BarclaysBarclays analyst Carter Gould raised the firm’s price target on Amgen to $315 from $300 and keeps an Equal Weight rating on the shares as part of an earnings pr...